Cyxone screens first patient in Phase II Covid-19 trial
Cyxone has announced the screening of the first participant in the Phase II clinical trial...
Galapagos doses first patient in Phase II GLPG1205 trial
Galapagos has dosed the first patient in the Phase II PINTA trial designed to evaluate...